Javascript doit fonctionner ! Activez-le et rechargez cette page.
Le Rézo de JeuxDeMots
• Types de relations
• Types de noeuds
• Consolider
le terme
  Options  
             

  Filtrage type relations : +   - (ex: 4, 12, 18, 36, 444, 555, 777)
  Filtrage valeur :          min   max
  Filtrage type noeuds :   +   - (ex: 4, 6, 8, 9, 10, 12, 18, 36, 444, 555, 777)

  Présentation de sortie :   (ex: -rien-, cloud, nicecloud)
 

'en:alpha-adrenergic agonist'
(id=6930382 ; fe=en:alpha-adrenergic agonist ; type=1 ; niveau=200 ; luminosité=25 ; somme entrante=4117 creation date=2017-06-25 touchdate=2025-07-16 16:21:32.000)
≈ 125 relations sortantes

  1. en:alpha-adrenergic agonist -- r_associated #0: 43 / 1 -> en:cardiac adrenergic blocking agent
    n1=en:alpha-adrenergic agonist | n2=en:cardiac adrenergic blocking agent | rel=r_associated | relid=0 | w=43
  2. en:alpha-adrenergic agonist -- r_associated #0: 43 / 1 -> sympathomimétiques alpha
    n1=en:alpha-adrenergic agonist | n2=sympathomimétiques alpha | rel=r_associated | relid=0 | w=43
  3. en:alpha-adrenergic agonist -- r_associated #0: 42 / 0.977 -> en:therapeutic epinephrine
    n1=en:alpha-adrenergic agonist | n2=en:therapeutic epinephrine | rel=r_associated | relid=0 | w=42
  4. en:alpha-adrenergic agonist -- r_associated #0: 41 / 0.953 -> en:ethylnorepinephrine
    n1=en:alpha-adrenergic agonist | n2=en:ethylnorepinephrine | rel=r_associated | relid=0 | w=41
  5. en:alpha-adrenergic agonist -- r_associated #0: 39 / 0.907 -> en:chemical aspects
    n1=en:alpha-adrenergic agonist | n2=en:chemical aspects | rel=r_associated | relid=0 | w=39
  6. en:alpha-adrenergic agonist -- r_associated #0: 39 / 0.907 -> en:mephentermine
    n1=en:alpha-adrenergic agonist | n2=en:mephentermine | rel=r_associated | relid=0 | w=39
  7. en:alpha-adrenergic agonist -- r_associated #0: 39 / 0.907 -> en:vasopressor
    n1=en:alpha-adrenergic agonist | n2=en:vasopressor | rel=r_associated | relid=0 | w=39
  8. en:alpha-adrenergic agonist -- r_associated #0: 38 / 0.884 -> en:besipirdine hydrochloride
    n1=en:alpha-adrenergic agonist | n2=en:besipirdine hydrochloride | rel=r_associated | relid=0 | w=38
  9. en:alpha-adrenergic agonist -- r_associated #0: 38 / 0.884 -> en:vasodilating agent
    n1=en:alpha-adrenergic agonist | n2=en:vasodilating agent | rel=r_associated | relid=0 | w=38
  10. en:alpha-adrenergic agonist -- r_associated #0: 37 / 0.86 -> en:ibopamine
    n1=en:alpha-adrenergic agonist | n2=en:ibopamine | rel=r_associated | relid=0 | w=37
  11. en:alpha-adrenergic agonist -- r_associated #0: 36 / 0.837 -> en:clorprenaline
    n1=en:alpha-adrenergic agonist | n2=en:clorprenaline | rel=r_associated | relid=0 | w=36
  12. en:alpha-adrenergic agonist -- r_associated #0: 35 / 0.814 -> en:adrenalone hydrochloride
    n1=en:alpha-adrenergic agonist | n2=en:adrenalone hydrochloride | rel=r_associated | relid=0 | w=35
  13. en:alpha-adrenergic agonist -- r_associated #0: 35 / 0.814 -> en:antiarrhythmic agent
    n1=en:alpha-adrenergic agonist | n2=en:antiarrhythmic agent | rel=r_associated | relid=0 | w=35
  14. en:alpha-adrenergic agonist -- r_associated #0: 35 / 0.814 -> en:cinnamedrine
    n1=en:alpha-adrenergic agonist | n2=en:cinnamedrine | rel=r_associated | relid=0 | w=35
  15. en:alpha-adrenergic agonist -- r_associated #0: 35 / 0.814 -> en:dl-methylephedrine
    n1=en:alpha-adrenergic agonist | n2=en:dl-methylephedrine | rel=r_associated | relid=0 | w=35
  16. en:alpha-adrenergic agonist -- r_associated #0: 35 / 0.814 -> en:epinephrine hydrochloride
    n1=en:alpha-adrenergic agonist | n2=en:epinephrine hydrochloride | rel=r_associated | relid=0 | w=35
  17. en:alpha-adrenergic agonist -- r_associated #0: 35 / 0.814 -> en:guanfacine
    n1=en:alpha-adrenergic agonist | n2=en:guanfacine | rel=r_associated | relid=0 | w=35
  18. en:alpha-adrenergic agonist -- r_associated #0: 35 / 0.814 -> en:metaterol
    n1=en:alpha-adrenergic agonist | n2=en:metaterol | rel=r_associated | relid=0 | w=35
  19. en:alpha-adrenergic agonist -- r_associated #0: 35 / 0.814 -> en:midodrine
    n1=en:alpha-adrenergic agonist | n2=en:midodrine | rel=r_associated | relid=0 | w=35
  20. en:alpha-adrenergic agonist -- r_associated #0: 35 / 0.814 -> en:pharmacokinetic aspects
    n1=en:alpha-adrenergic agonist | n2=en:pharmacokinetic aspects | rel=r_associated | relid=0 | w=35
  21. en:alpha-adrenergic agonist -- r_associated #0: 35 / 0.814 -> en:potassium-sparing diuretic
    n1=en:alpha-adrenergic agonist | n2=en:potassium-sparing diuretic | rel=r_associated | relid=0 | w=35
  22. en:alpha-adrenergic agonist -- r_associated #0: 35 / 0.814 -> en:sclerosing solutions
    n1=en:alpha-adrenergic agonist | n2=en:sclerosing solutions | rel=r_associated | relid=0 | w=35
  23. en:alpha-adrenergic agonist -- r_associated #0: 34 / 0.791 -> en:adrenergic alpha-agonists
    n1=en:alpha-adrenergic agonist | n2=en:adrenergic alpha-agonists | rel=r_associated | relid=0 | w=34
  24. en:alpha-adrenergic agonist -- r_associated #0: 34 / 0.791 -> en:alpha-adrenergic agonist [epc]
    n1=en:alpha-adrenergic agonist | n2=en:alpha-adrenergic agonist [epc] | rel=r_associated | relid=0 | w=34
  25. en:alpha-adrenergic agonist -- r_associated #0: 34 / 0.791 -> en:epinephryl borate
    n1=en:alpha-adrenergic agonist | n2=en:epinephryl borate | rel=r_associated | relid=0 | w=34
  26. en:alpha-adrenergic agonist -- r_associated #0: 34 / 0.791 -> en:historical aspects qualifier
    n1=en:alpha-adrenergic agonist | n2=en:historical aspects qualifier | rel=r_associated | relid=0 | w=34
  27. en:alpha-adrenergic agonist -- r_associated #0: 34 / 0.791 -> en:neurotransmitter uptake inhibitors
    n1=en:alpha-adrenergic agonist | n2=en:neurotransmitter uptake inhibitors | rel=r_associated | relid=0 | w=34
  28. en:alpha-adrenergic agonist -- r_associated #0: 34 / 0.791 -> en:norepinephrine, dl-
    n1=en:alpha-adrenergic agonist | n2=en:norepinephrine, dl- | rel=r_associated | relid=0 | w=34
  29. en:alpha-adrenergic agonist -- r_associated #0: 34 / 0.791 -> en:phenylpropanolamine hydrochloride
    n1=en:alpha-adrenergic agonist | n2=en:phenylpropanolamine hydrochloride | rel=r_associated | relid=0 | w=34
  30. en:alpha-adrenergic agonist -- r_associated #0: 34 / 0.791 -> en:synephrine
    n1=en:alpha-adrenergic agonist | n2=en:synephrine | rel=r_associated | relid=0 | w=34
  31. en:alpha-adrenergic agonist -- r_associated #0: 34 / 0.791 -> en:taxonomic
    n1=en:alpha-adrenergic agonist | n2=en:taxonomic | rel=r_associated | relid=0 | w=34
  32. en:alpha-adrenergic agonist -- r_associated #0: 34 / 0.791 -> en:vasoprotectant
    n1=en:alpha-adrenergic agonist | n2=en:vasoprotectant | rel=r_associated | relid=0 | w=34
  33. en:alpha-adrenergic agonist -- r_associated #0: 32 / 0.744 -> agonistes des récepteurs alpha-adrénergiques
    n1=en:alpha-adrenergic agonist | n2=agonistes des récepteurs alpha-adrénergiques | rel=r_associated | relid=0 | w=32
  34. en:alpha-adrenergic agonist -- r_associated #0: 32 / 0.744 -> en:adrenergic alpha-1 receptor agonists
    n1=en:alpha-adrenergic agonist | n2=en:adrenergic alpha-1 receptor agonists | rel=r_associated | relid=0 | w=32
  35. en:alpha-adrenergic agonist -- r_associated #0: 32 / 0.744 -> en:angiotensin ii receptor antagonist
    n1=en:alpha-adrenergic agonist | n2=en:angiotensin ii receptor antagonist | rel=r_associated | relid=0 | w=32
  36. en:alpha-adrenergic agonist -- r_associated #0: 32 / 0.744 -> en:calcium channel blocker
    n1=en:alpha-adrenergic agonist | n2=en:calcium channel blocker | rel=r_associated | relid=0 | w=32
  37. en:alpha-adrenergic agonist -- r_associated #0: 32 / 0.744 -> en:cardioplegic solutions
    n1=en:alpha-adrenergic agonist | n2=en:cardioplegic solutions | rel=r_associated | relid=0 | w=32
  38. en:alpha-adrenergic agonist -- r_associated #0: 32 / 0.744 -> en:digitalis glycosides
    n1=en:alpha-adrenergic agonist | n2=en:digitalis glycosides | rel=r_associated | relid=0 | w=32
  39. en:alpha-adrenergic agonist -- r_associated #0: 32 / 0.744 -> en:droxidopa
    n1=en:alpha-adrenergic agonist | n2=en:droxidopa | rel=r_associated | relid=0 | w=32
  40. en:alpha-adrenergic agonist -- r_associated #0: 32 / 0.744 -> en:dyslipidemics, other
    n1=en:alpha-adrenergic agonist | n2=en:dyslipidemics, other | rel=r_associated | relid=0 | w=32
  41. en:alpha-adrenergic agonist -- r_associated #0: 32 / 0.744 -> en:lergotrile
    n1=en:alpha-adrenergic agonist | n2=en:lergotrile | rel=r_associated | relid=0 | w=32
  42. en:alpha-adrenergic agonist -- r_associated #0: 32 / 0.744 -> en:vasodilators, direct-acting arterial
    n1=en:alpha-adrenergic agonist | n2=en:vasodilators, direct-acting arterial | rel=r_associated | relid=0 | w=32
  43. en:alpha-adrenergic agonist -- r_associated #0: 31 / 0.721 -> en:adrenalone
    n1=en:alpha-adrenergic agonist | n2=en:adrenalone | rel=r_associated | relid=0 | w=31
  44. en:alpha-adrenergic agonist -- r_associated #0: 31 / 0.721 -> en:adrenergic alpha-2 receptor agonists
    n1=en:alpha-adrenergic agonist | n2=en:adrenergic alpha-2 receptor agonists | rel=r_associated | relid=0 | w=31
  45. en:alpha-adrenergic agonist -- r_associated #0: 31 / 0.721 -> en:clonidine
    n1=en:alpha-adrenergic agonist | n2=en:clonidine | rel=r_associated | relid=0 | w=31
  46. en:alpha-adrenergic agonist -- r_associated #0: 31 / 0.721 -> en:diuretic
    n1=en:alpha-adrenergic agonist | n2=en:diuretic | rel=r_associated | relid=0 | w=31
  47. en:alpha-adrenergic agonist -- r_associated #0: 31 / 0.721 -> en:in urine
    n1=en:alpha-adrenergic agonist | n2=en:in urine | rel=r_associated | relid=0 | w=31
  48. en:alpha-adrenergic agonist -- r_associated #0: 31 / 0.721 -> en:methyldopa
    n1=en:alpha-adrenergic agonist | n2=en:methyldopa | rel=r_associated | relid=0 | w=31
  49. en:alpha-adrenergic agonist -- r_associated #0: 31 / 0.721 -> en:phenylephrine
    n1=en:alpha-adrenergic agonist | n2=en:phenylephrine | rel=r_associated | relid=0 | w=31
  50. en:alpha-adrenergic agonist -- r_associated #0: 31 / 0.721 -> en:phenylpropanolamine
    n1=en:alpha-adrenergic agonist | n2=en:phenylpropanolamine | rel=r_associated | relid=0 | w=31
  51. en:alpha-adrenergic agonist -- r_associated #0: 31 / 0.721 -> en:standards characteristics
    n1=en:alpha-adrenergic agonist | n2=en:standards characteristics | rel=r_associated | relid=0 | w=31
  52. en:alpha-adrenergic agonist -- r_associated #0: 30 / 0.698 -> en:aspirin/simvastatin/atenolol/ramipril/thiazide capsule
    n1=en:alpha-adrenergic agonist | n2=en:aspirin/simvastatin/atenolol/ramipril/thiazide capsule | rel=r_associated | relid=0 | w=30
  53. en:alpha-adrenergic agonist -- r_associated #0: 30 / 0.698 -> en:beta-adrenergic agonist
    n1=en:alpha-adrenergic agonist | n2=en:beta-adrenergic agonist | rel=r_associated | relid=0 | w=30
  54. en:alpha-adrenergic agonist -- r_associated #0: 30 / 0.698 -> en:cardiovascular agents, other
    n1=en:alpha-adrenergic agonist | n2=en:cardiovascular agents, other | rel=r_associated | relid=0 | w=30
  55. en:alpha-adrenergic agonist -- r_associated #0: 30 / 0.698 -> en:dyslipidemics, fibric acid derivatives
    n1=en:alpha-adrenergic agonist | n2=en:dyslipidemics, fibric acid derivatives | rel=r_associated | relid=0 | w=30
  56. en:alpha-adrenergic agonist -- r_associated #0: 30 / 0.698 -> en:epinephrine bitartrate
    n1=en:alpha-adrenergic agonist | n2=en:epinephrine bitartrate | rel=r_associated | relid=0 | w=30
  57. en:alpha-adrenergic agonist -- r_associated #0: 30 / 0.698 -> en:l-norepinephrine
    n1=en:alpha-adrenergic agonist | n2=en:l-norepinephrine | rel=r_associated | relid=0 | w=30
  58. en:alpha-adrenergic agonist -- r_associated #0: 30 / 0.698 -> en:methylaminoheptane
    n1=en:alpha-adrenergic agonist | n2=en:methylaminoheptane | rel=r_associated | relid=0 | w=30
  59. en:alpha-adrenergic agonist -- r_associated #0: 30 / 0.698 -> en:octopamine
    n1=en:alpha-adrenergic agonist | n2=en:octopamine | rel=r_associated | relid=0 | w=30
  60. en:alpha-adrenergic agonist -- r_associated #0: 29 / 0.674 -> en:antihypertensive agent
    n1=en:alpha-adrenergic agonist | n2=en:antihypertensive agent | rel=r_associated | relid=0 | w=29
  61. en:alpha-adrenergic agonist -- r_associated #0: 29 / 0.674 -> en:antilipemic agent
    n1=en:alpha-adrenergic agonist | n2=en:antilipemic agent | rel=r_associated | relid=0 | w=29
  62. en:alpha-adrenergic agonist -- r_associated #0: 29 / 0.674 -> en:cardiotonic agent
    n1=en:alpha-adrenergic agonist | n2=en:cardiotonic agent | rel=r_associated | relid=0 | w=29
  63. en:alpha-adrenergic agonist -- r_associated #0: 29 / 0.674 -> en:cinnamedrine hydrochloride
    n1=en:alpha-adrenergic agonist | n2=en:cinnamedrine hydrochloride | rel=r_associated | relid=0 | w=29
  64. en:alpha-adrenergic agonist -- r_associated #0: 29 / 0.674 -> en:ephedrine sulfate
    n1=en:alpha-adrenergic agonist | n2=en:ephedrine sulfate | rel=r_associated | relid=0 | w=29
  65. en:alpha-adrenergic agonist -- r_associated #0: 29 / 0.674 -> en:methyldopate
    n1=en:alpha-adrenergic agonist | n2=en:methyldopate | rel=r_associated | relid=0 | w=29
  66. en:alpha-adrenergic agonist -- r_associated #0: 29 / 0.674 -> en:racephedrine
    n1=en:alpha-adrenergic agonist | n2=en:racephedrine | rel=r_associated | relid=0 | w=29
  67. en:alpha-adrenergic agonist -- r_associated #0: 29 / 0.674 -> en:sodium channel blockers
    n1=en:alpha-adrenergic agonist | n2=en:sodium channel blockers | rel=r_associated | relid=0 | w=29
  68. en:alpha-adrenergic agonist -- r_associated #0: 28 / 0.651 -> agoniste alpha-adrénergique
    n1=en:alpha-adrenergic agonist | n2=agoniste alpha-adrénergique | rel=r_associated | relid=0 | w=28
  69. en:alpha-adrenergic agonist -- r_associated #0: 28 / 0.651 -> en:adrenergic agonist
    n1=en:alpha-adrenergic agonist | n2=en:adrenergic agonist | rel=r_associated | relid=0 | w=28
  70. en:alpha-adrenergic agonist -- r_associated #0: 28 / 0.651 -> en:antiatherogenic agent
    n1=en:alpha-adrenergic agonist | n2=en:antiatherogenic agent | rel=r_associated | relid=0 | w=28
  71. en:alpha-adrenergic agonist -- r_associated #0: 28 / 0.651 -> en:antiplatelet agent
    n1=en:alpha-adrenergic agonist | n2=en:antiplatelet agent | rel=r_associated | relid=0 | w=28
  72. en:alpha-adrenergic agonist -- r_associated #0: 28 / 0.651 -> en:contraindications aspect
    n1=en:alpha-adrenergic agonist | n2=en:contraindications aspect | rel=r_associated | relid=0 | w=28
  73. en:alpha-adrenergic agonist -- r_associated #0: 28 / 0.651 -> en:dl-methylephedrine hydrochloride
    n1=en:alpha-adrenergic agonist | n2=en:dl-methylephedrine hydrochloride | rel=r_associated | relid=0 | w=28
  74. en:alpha-adrenergic agonist -- r_associated #0: 28 / 0.651 -> en:ephedrine
    n1=en:alpha-adrenergic agonist | n2=en:ephedrine | rel=r_associated | relid=0 | w=28
  75. en:alpha-adrenergic agonist -- r_associated #0: 28 / 0.651 -> en:immunology aspects
    n1=en:alpha-adrenergic agonist | n2=en:immunology aspects | rel=r_associated | relid=0 | w=28
  76. en:alpha-adrenergic agonist -- r_associated #0: 28 / 0.651 -> en:mechanism of action qualifier
    n1=en:alpha-adrenergic agonist | n2=en:mechanism of action qualifier | rel=r_associated | relid=0 | w=28
  77. en:alpha-adrenergic agonist -- r_associated #0: 28 / 0.651 -> en:natriuretic agents
    n1=en:alpha-adrenergic agonist | n2=en:natriuretic agents | rel=r_associated | relid=0 | w=28
  78. en:alpha-adrenergic agonist -- r_associated #0: 28 / 0.651 -> en:nitric oxide donors
    n1=en:alpha-adrenergic agonist | n2=en:nitric oxide donors | rel=r_associated | relid=0 | w=28
  79. en:alpha-adrenergic agonist -- r_associated #0: 28 / 0.651 -> en:nordefrin
    n1=en:alpha-adrenergic agonist | n2=en:nordefrin | rel=r_associated | relid=0 | w=28
  80. en:alpha-adrenergic agonist -- r_associated #0: 28 / 0.651 -> en:potassium channel blockers
    n1=en:alpha-adrenergic agonist | n2=en:potassium channel blockers | rel=r_associated | relid=0 | w=28
  81. en:alpha-adrenergic agonist -- r_associated #0: 28 / 0.651 -> en:thrombolytic agent
    n1=en:alpha-adrenergic agonist | n2=en:thrombolytic agent | rel=r_associated | relid=0 | w=28
  82. en:alpha-adrenergic agonist -- r_associated #0: 27 / 0.628 -> agonistes alpha-adrénergiques
    n1=en:alpha-adrenergic agonist | n2=agonistes alpha-adrénergiques | rel=r_associated | relid=0 | w=27
  83. en:alpha-adrenergic agonist -- r_associated #0: 27 / 0.628 -> en:adrenergic alpha-2 adrenergic agonists
    n1=en:alpha-adrenergic agonist | n2=en:adrenergic alpha-2 adrenergic agonists | rel=r_associated | relid=0 | w=27
  84. en:alpha-adrenergic agonist -- r_associated #0: 27 / 0.628 -> en:agent affecting cardiovascular system
    n1=en:alpha-adrenergic agonist | n2=en:agent affecting cardiovascular system | rel=r_associated | relid=0 | w=27
  85. en:alpha-adrenergic agonist -- r_associated #0: 27 / 0.628 -> en:alpha blockers/related
    n1=en:alpha-adrenergic agonist | n2=en:alpha blockers/related | rel=r_associated | relid=0 | w=27
  86. en:alpha-adrenergic agonist -- r_associated #0: 27 / 0.628 -> en:araminol
    n1=en:alpha-adrenergic agonist | n2=en:araminol | rel=r_associated | relid=0 | w=27
  87. en:alpha-adrenergic agonist -- r_associated #0: 27 / 0.628 -> en:arrhythmic agent
    n1=en:alpha-adrenergic agonist | n2=en:arrhythmic agent | rel=r_associated | relid=0 | w=27
  88. en:alpha-adrenergic agonist -- r_associated #0: 27 / 0.628 -> en:aspects of adverse effects
    n1=en:alpha-adrenergic agonist | n2=en:aspects of adverse effects | rel=r_associated | relid=0 | w=27
  89. en:alpha-adrenergic agonist -- r_associated #0: 27 / 0.628 -> en:nordefrin hydrochloride
    n1=en:alpha-adrenergic agonist | n2=en:nordefrin hydrochloride | rel=r_associated | relid=0 | w=27
  90. en:alpha-adrenergic agonist -- r_associated #0: 27 / 0.628 -> en:sclerosing agent
    n1=en:alpha-adrenergic agonist | n2=en:sclerosing agent | rel=r_associated | relid=0 | w=27
  91. en:alpha-adrenergic agonist -- r_associated #0: 27 / 0.628 -> en:tinofedrine
    n1=en:alpha-adrenergic agonist | n2=en:tinofedrine | rel=r_associated | relid=0 | w=27
  92. en:alpha-adrenergic agonist -- r_associated #0: 26 / 0.605 -> en:ace inhibitor
    n1=en:alpha-adrenergic agonist | n2=en:ace inhibitor | rel=r_associated | relid=0 | w=26
  93. en:alpha-adrenergic agonist -- r_associated #0: 26 / 0.605 -> en:antianginals
    n1=en:alpha-adrenergic agonist | n2=en:antianginals | rel=r_associated | relid=0 | w=26
  94. en:alpha-adrenergic agonist -- r_associated #0: 26 / 0.605 -> en:antihypertensives, other
    n1=en:alpha-adrenergic agonist | n2=en:antihypertensives, other | rel=r_associated | relid=0 | w=26
  95. en:alpha-adrenergic agonist -- r_associated #0: 26 / 0.605 -> en:beta-adrenergic antagonist
    n1=en:alpha-adrenergic agonist | n2=en:beta-adrenergic antagonist | rel=r_associated | relid=0 | w=26
  96. en:alpha-adrenergic agonist -- r_associated #0: 26 / 0.605 -> en:calcium channel agonists
    n1=en:alpha-adrenergic agonist | n2=en:calcium channel agonists | rel=r_associated | relid=0 | w=26
  97. en:alpha-adrenergic agonist -- r_associated #0: 26 / 0.605 -> en:dipivefrin
    n1=en:alpha-adrenergic agonist | n2=en:dipivefrin | rel=r_associated | relid=0 | w=26
  98. en:alpha-adrenergic agonist -- r_associated #0: 26 / 0.605 -> en:hydroxyamphetamine
    n1=en:alpha-adrenergic agonist | n2=en:hydroxyamphetamine | rel=r_associated | relid=0 | w=26
  99. en:alpha-adrenergic agonist -- r_associated #0: 26 / 0.605 -> en:in blood
    n1=en:alpha-adrenergic agonist | n2=en:in blood | rel=r_associated | relid=0 | w=26
  100. en:alpha-adrenergic agonist -- r_associated #0: 26 / 0.605 -> en:levonordefrin
    n1=en:alpha-adrenergic agonist | n2=en:levonordefrin | rel=r_associated | relid=0 | w=26
  101. en:alpha-adrenergic agonist -- r_associated #0: 26 / 0.605 -> en:pholedrine
    n1=en:alpha-adrenergic agonist | n2=en:pholedrine | rel=r_associated | relid=0 | w=26
  102. en:alpha-adrenergic agonist -- r_associated #0: 26 / 0.605 -> en:poisoning by predominantly alpha-adrenoreceptor agonists, nec in icd10am_2000
    n1=en:alpha-adrenergic agonist | n2=en:poisoning by predominantly alpha-adrenoreceptor agonists, nec in icd10am_2000 | rel=r_associated | relid=0 | w=26
  103. en:alpha-adrenergic agonist -- r_associated #0: 26 / 0.605 -> en:therapeutic use - qualifier
    n1=en:alpha-adrenergic agonist | n2=en:therapeutic use - qualifier | rel=r_associated | relid=0 | w=26
  104. en:alpha-adrenergic agonist -- r_associated #0: 26 / 0.605 -> en:toxicity aspects
    n1=en:alpha-adrenergic agonist | n2=en:toxicity aspects | rel=r_associated | relid=0 | w=26
  105. en:alpha-adrenergic agonist -- r_associated #0: 26 / 0.605 -> en:vasoactive agent
    n1=en:alpha-adrenergic agonist | n2=en:vasoactive agent | rel=r_associated | relid=0 | w=26
  106. en:alpha-adrenergic agonist -- r_associated #0: 25 / 0.581 -> en:etafedrine
    n1=en:alpha-adrenergic agonist | n2=en:etafedrine | rel=r_associated | relid=0 | w=25
  107. en:alpha-adrenergic agonist -- r_associated #0: 24 / 0.558 -> en:etilefrine
    n1=en:alpha-adrenergic agonist | n2=en:etilefrine | rel=r_associated | relid=0 | w=24
  108. en:alpha-adrenergic agonist -- r_associated #0: 21 / 0.488 -> en:cyclopentamine
    n1=en:alpha-adrenergic agonist | n2=en:cyclopentamine | rel=r_associated | relid=0 | w=21
  109. en:alpha-adrenergic agonist -- r_associated #0: 21 / 0.488 -> en:exposure as collected domain
    n1=en:alpha-adrenergic agonist | n2=en:exposure as collected domain | rel=r_associated | relid=0 | w=21
  110. en:alpha-adrenergic agonist -- r_associated #0: 20 / 0.465 -> agent vasodilatateur
    n1=en:alpha-adrenergic agonist | n2=agent vasodilatateur | rel=r_associated | relid=0 | w=20
  111. en:alpha-adrenergic agonist -- r_associated #0: 20 / 0.465 -> en:alpha-adrenergic antagonist
    n1=en:alpha-adrenergic agonist | n2=en:alpha-adrenergic antagonist | rel=r_associated | relid=0 | w=20
  112. en:alpha-adrenergic agonist -- r_associated #0: 20 / 0.465 -> en:calcium channel inhibitor
    n1=en:alpha-adrenergic agonist | n2=en:calcium channel inhibitor | rel=r_associated | relid=0 | w=20
  113. en:alpha-adrenergic agonist -- r_associated #0: 20 / 0.465 -> en:epinastine
    n1=en:alpha-adrenergic agonist | n2=en:epinastine | rel=r_associated | relid=0 | w=20
  114. en:alpha-adrenergic agonist -- r_associated #0: 20 / 0.465 -> en:oxedrine tartrate
    n1=en:alpha-adrenergic agonist | n2=en:oxedrine tartrate | rel=r_associated | relid=0 | w=20
  115. en:alpha-adrenergic agonist -- r_associated #0: 20 / 0.465 -> en:phenylpropylmethylamine
    n1=en:alpha-adrenergic agonist | n2=en:phenylpropylmethylamine | rel=r_associated | relid=0 | w=20
  116. en:alpha-adrenergic agonist -- r_associated #0: 20 / 0.465 -> en:synephrin
    n1=en:alpha-adrenergic agonist | n2=en:synephrin | rel=r_associated | relid=0 | w=20
  117. en:alpha-adrenergic agonist -- r_associated #0: 20 / 0.465 -> inhibiteur des canaux calciques
    n1=en:alpha-adrenergic agonist | n2=inhibiteur des canaux calciques | rel=r_associated | relid=0 | w=20
  118. en:alpha-adrenergic agonist -- r_associated #0: 20 / 0.465 -> lergotrile
    n1=en:alpha-adrenergic agonist | n2=lergotrile | rel=r_associated | relid=0 | w=20
  119. en:alpha-adrenergic agonist -- r_associated #0: 20 / 0.465 -> midodrine
    n1=en:alpha-adrenergic agonist | n2=midodrine | rel=r_associated | relid=0 | w=20
  120. en:alpha-adrenergic agonist -- r_associated #0: 20 / 0.465 -> phénylpropylméthylamine
    n1=en:alpha-adrenergic agonist | n2=phénylpropylméthylamine | rel=r_associated | relid=0 | w=20
  121. en:alpha-adrenergic agonist -- r_associated #0: 20 / 0.465 -> synéphrine
    n1=en:alpha-adrenergic agonist | n2=synéphrine | rel=r_associated | relid=0 | w=20
  122. en:alpha-adrenergic agonist -- r_associated #0: 20 / 0.465 -> thrombolytique
    n1=en:alpha-adrenergic agonist | n2=thrombolytique | rel=r_associated | relid=0 | w=20
  123. en:alpha-adrenergic agonist -- r_associated #0: 20 / 0.465 -> thrombolytique (médicament)
    n1=en:alpha-adrenergic agonist | n2=thrombolytique (médicament) | rel=r_associated | relid=0 | w=20
  124. en:alpha-adrenergic agonist -- r_associated #0: 20 / 0.465 -> vasodilatateur
    n1=en:alpha-adrenergic agonist | n2=vasodilatateur | rel=r_associated | relid=0 | w=20
  125. en:alpha-adrenergic agonist -- r_associated #0: 2 / 0.047 -> en:pharmacologic substance
    n1=en:alpha-adrenergic agonist | n2=en:pharmacologic substance | rel=r_associated | relid=0 | w=2
≈ 139 relations entrantes

  1. en:vasodilating agent --- r_associated #0: 110 --> en:alpha-adrenergic agonist
    n1=en:vasodilating agent | n2=en:alpha-adrenergic agonist | rel=r_associated | relid=0 | w=110
  2. agent vasodilatateur --- r_associated #0: 108 --> en:alpha-adrenergic agonist
    n1=agent vasodilatateur | n2=en:alpha-adrenergic agonist | rel=r_associated | relid=0 | w=108
  3. midodrine --- r_associated #0: 98 --> en:alpha-adrenergic agonist
    n1=midodrine | n2=en:alpha-adrenergic agonist | rel=r_associated | relid=0 | w=98
  4. phénylpropylméthylamine --- r_associated #0: 96 --> en:alpha-adrenergic agonist
    n1=phénylpropylméthylamine | n2=en:alpha-adrenergic agonist | rel=r_associated | relid=0 | w=96
  5. en:midodrine --- r_associated #0: 95 --> en:alpha-adrenergic agonist
    n1=en:midodrine | n2=en:alpha-adrenergic agonist | rel=r_associated | relid=0 | w=95
  6. en:phenylpropylmethylamine --- r_associated #0: 95 --> en:alpha-adrenergic agonist
    n1=en:phenylpropylmethylamine | n2=en:alpha-adrenergic agonist | rel=r_associated | relid=0 | w=95
  7. vasodilatateur --- r_associated #0: 95 --> en:alpha-adrenergic agonist
    n1=vasodilatateur | n2=en:alpha-adrenergic agonist | rel=r_associated | relid=0 | w=95
  8. synéphrine --- r_associated #0: 85 --> en:alpha-adrenergic agonist
    n1=synéphrine | n2=en:alpha-adrenergic agonist | rel=r_associated | relid=0 | w=85
  9. en:synephrine --- r_associated #0: 84 --> en:alpha-adrenergic agonist
    n1=en:synephrine | n2=en:alpha-adrenergic agonist | rel=r_associated | relid=0 | w=84
  10. en:lergotrile --- r_associated #0: 68 --> en:alpha-adrenergic agonist
    n1=en:lergotrile | n2=en:alpha-adrenergic agonist | rel=r_associated | relid=0 | w=68
  11. lergotrile --- r_associated #0: 66 --> en:alpha-adrenergic agonist
    n1=lergotrile | n2=en:alpha-adrenergic agonist | rel=r_associated | relid=0 | w=66
  12. en:synephrin --- r_associated #0: 50 --> en:alpha-adrenergic agonist
    n1=en:synephrin | n2=en:alpha-adrenergic agonist | rel=r_associated | relid=0 | w=50
  13. thrombolytique --- r_associated #0: 47 --> en:alpha-adrenergic agonist
    n1=thrombolytique | n2=en:alpha-adrenergic agonist | rel=r_associated | relid=0 | w=47
  14. en:thrombolytic agent --- r_associated #0: 44 --> en:alpha-adrenergic agonist
    n1=en:thrombolytic agent | n2=en:alpha-adrenergic agonist | rel=r_associated | relid=0 | w=44
  15. en:mechanism of action qualifier --- r_associated #0: 43 --> en:alpha-adrenergic agonist
    n1=en:mechanism of action qualifier | n2=en:alpha-adrenergic agonist | rel=r_associated | relid=0 | w=43
  16. thrombolytique (médicament) --- r_associated #0: 41 --> en:alpha-adrenergic agonist
    n1=thrombolytique (médicament) | n2=en:alpha-adrenergic agonist | rel=r_associated | relid=0 | w=41
  17. en:pholedrine --- r_associated #0: 40 --> en:alpha-adrenergic agonist
    n1=en:pholedrine | n2=en:alpha-adrenergic agonist | rel=r_associated | relid=0 | w=40
  18. en:nordefrin hydrochloride --- r_associated #0: 39 --> en:alpha-adrenergic agonist
    n1=en:nordefrin hydrochloride | n2=en:alpha-adrenergic agonist | rel=r_associated | relid=0 | w=39
  19. en:calcium channel blocker --- r_associated #0: 37 --> en:alpha-adrenergic agonist
    n1=en:calcium channel blocker | n2=en:alpha-adrenergic agonist | rel=r_associated | relid=0 | w=37
  20. inhibiteur des canaux calciques --- r_associated #0: 36 --> en:alpha-adrenergic agonist
    n1=inhibiteur des canaux calciques | n2=en:alpha-adrenergic agonist | rel=r_associated | relid=0 | w=36
  21. en:adrenalone --- r_associated #0: 35 --> en:alpha-adrenergic agonist
    n1=en:adrenalone | n2=en:alpha-adrenergic agonist | rel=r_associated | relid=0 | w=35
  22. en:adrenergic alpha-1 receptor agonists --- r_associated #0: 35 --> en:alpha-adrenergic agonist
    n1=en:adrenergic alpha-1 receptor agonists | n2=en:alpha-adrenergic agonist | rel=r_associated | relid=0 | w=35
  23. en:etafedrine --- r_associated #0: 35 --> en:alpha-adrenergic agonist
    n1=en:etafedrine | n2=en:alpha-adrenergic agonist | rel=r_associated | relid=0 | w=35
  24. en:natriuretic agents --- r_associated #0: 35 --> en:alpha-adrenergic agonist
    n1=en:natriuretic agents | n2=en:alpha-adrenergic agonist | rel=r_associated | relid=0 | w=35
  25. en:antihypertensive agent --- r_associated #0: 34 --> en:alpha-adrenergic agonist
    n1=en:antihypertensive agent | n2=en:alpha-adrenergic agonist | rel=r_associated | relid=0 | w=34
  26. en:nordefrin --- r_associated #0: 34 --> en:alpha-adrenergic agonist
    n1=en:nordefrin | n2=en:alpha-adrenergic agonist | rel=r_associated | relid=0 | w=34
  27. en:standards characteristics --- r_associated #0: 34 --> en:alpha-adrenergic agonist
    n1=en:standards characteristics | n2=en:alpha-adrenergic agonist | rel=r_associated | relid=0 | w=34
  28. en:therapeutic epinephrine --- r_associated #0: 34 --> en:alpha-adrenergic agonist
    n1=en:therapeutic epinephrine | n2=en:alpha-adrenergic agonist | rel=r_associated | relid=0 | w=34
  29. en:droxidopa --- r_associated #0: 32 --> en:alpha-adrenergic agonist
    n1=en:droxidopa | n2=en:alpha-adrenergic agonist | rel=r_associated | relid=0 | w=32
  30. en:calcium channel inhibitor --- r_associated #0: 31 --> en:alpha-adrenergic agonist
    n1=en:calcium channel inhibitor | n2=en:alpha-adrenergic agonist | rel=r_associated | relid=0 | w=31
  31. en:cardiotonic agent --- r_associated #0: 31 --> en:alpha-adrenergic agonist
    n1=en:cardiotonic agent | n2=en:alpha-adrenergic agonist | rel=r_associated | relid=0 | w=31
  32. en:epinephryl borate --- r_associated #0: 31 --> en:alpha-adrenergic agonist
    n1=en:epinephryl borate | n2=en:alpha-adrenergic agonist | rel=r_associated | relid=0 | w=31
  33. en:immunology aspects --- r_associated #0: 31 --> en:alpha-adrenergic agonist
    n1=en:immunology aspects | n2=en:alpha-adrenergic agonist | rel=r_associated | relid=0 | w=31
  34. agonistes alpha-adrénergiques --- r_associated #0: 30 --> en:alpha-adrenergic agonist
    n1=agonistes alpha-adrénergiques | n2=en:alpha-adrenergic agonist | rel=r_associated | relid=0 | w=30
  35. agonistes des récepteurs alpha-adrénergiques --- r_associated #0: 30 --> en:alpha-adrenergic agonist
    n1=agonistes des récepteurs alpha-adrénergiques | n2=en:alpha-adrenergic agonist | rel=r_associated | relid=0 | w=30
  36. en:adrenergic alpha-agonists --- r_associated #0: 30 --> en:alpha-adrenergic agonist
    n1=en:adrenergic alpha-agonists | n2=en:alpha-adrenergic agonist | rel=r_associated | relid=0 | w=30
  37. en:guanfacine --- r_associated #0: 30 --> en:alpha-adrenergic agonist
    n1=en:guanfacine | n2=en:alpha-adrenergic agonist | rel=r_associated | relid=0 | w=30
  38. en:methylaminoheptane --- r_associated #0: 30 --> en:alpha-adrenergic agonist
    n1=en:methylaminoheptane | n2=en:alpha-adrenergic agonist | rel=r_associated | relid=0 | w=30
  39. en:pharmacokinetic aspects --- r_associated #0: 30 --> en:alpha-adrenergic agonist
    n1=en:pharmacokinetic aspects | n2=en:alpha-adrenergic agonist | rel=r_associated | relid=0 | w=30
  40. agoniste alpha-adrénergique --- r_associated #0: 29 --> en:alpha-adrenergic agonist
    n1=agoniste alpha-adrénergique | n2=en:alpha-adrenergic agonist | rel=r_associated | relid=0 | w=29
  41. en:epinastine --- r_associated #0: 29 --> en:alpha-adrenergic agonist
    n1=en:epinastine | n2=en:alpha-adrenergic agonist | rel=r_associated | relid=0 | w=29
  42. en:levonordefrin --- r_associated #0: 29 --> en:alpha-adrenergic agonist
    n1=en:levonordefrin | n2=en:alpha-adrenergic agonist | rel=r_associated | relid=0 | w=29
  43. en:norepinephrine, dl- --- r_associated #0: 29 --> en:alpha-adrenergic agonist
    n1=en:norepinephrine, dl- | n2=en:alpha-adrenergic agonist | rel=r_associated | relid=0 | w=29
  44. en:therapeutic use - qualifier --- r_associated #0: 29 --> en:alpha-adrenergic agonist
    n1=en:therapeutic use - qualifier | n2=en:alpha-adrenergic agonist | rel=r_associated | relid=0 | w=29
  45. en:alpha-adrenergic antagonist --- r_associated #0: 28 --> en:alpha-adrenergic agonist
    n1=en:alpha-adrenergic antagonist | n2=en:alpha-adrenergic agonist | rel=r_associated | relid=0 | w=28
  46. en:beta-adrenergic agonist --- r_associated #0: 28 --> en:alpha-adrenergic agonist
    n1=en:beta-adrenergic agonist | n2=en:alpha-adrenergic agonist | rel=r_associated | relid=0 | w=28
  47. en:cyclopentamine --- r_associated #0: 28 --> en:alpha-adrenergic agonist
    n1=en:cyclopentamine | n2=en:alpha-adrenergic agonist | rel=r_associated | relid=0 | w=28
  48. en:hydroxyamphetamine --- r_associated #0: 28 --> en:alpha-adrenergic agonist
    n1=en:hydroxyamphetamine | n2=en:alpha-adrenergic agonist | rel=r_associated | relid=0 | w=28
  49. en:oxedrine tartrate --- r_associated #0: 28 --> en:alpha-adrenergic agonist
    n1=en:oxedrine tartrate | n2=en:alpha-adrenergic agonist | rel=r_associated | relid=0 | w=28
  50. en:sodium channel blockers --- r_associated #0: 28 --> en:alpha-adrenergic agonist
    n1=en:sodium channel blockers | n2=en:alpha-adrenergic agonist | rel=r_associated | relid=0 | w=28
  51. en:antilipemic agent --- r_associated #0: 27 --> en:alpha-adrenergic agonist
    n1=en:antilipemic agent | n2=en:alpha-adrenergic agonist | rel=r_associated | relid=0 | w=27
  52. en:etilefrine --- r_associated #0: 27 --> en:alpha-adrenergic agonist
    n1=en:etilefrine | n2=en:alpha-adrenergic agonist | rel=r_associated | relid=0 | w=27
  53. en:exposure as collected domain --- r_associated #0: 27 --> en:alpha-adrenergic agonist
    n1=en:exposure as collected domain | n2=en:alpha-adrenergic agonist | rel=r_associated | relid=0 | w=27
  54. en:phenylpropanolamine hydrochloride --- r_associated #0: 27 --> en:alpha-adrenergic agonist
    n1=en:phenylpropanolamine hydrochloride | n2=en:alpha-adrenergic agonist | rel=r_associated | relid=0 | w=27
  55. en:poisoning by predominantly alpha-adrenoreceptor agonists, nec in icd10am_2000 --- r_associated #0: 27 --> en:alpha-adrenergic agonist
    n1=en:poisoning by predominantly alpha-adrenoreceptor agonists, nec in icd10am_2000 | n2=en:alpha-adrenergic agonist | rel=r_associated | relid=0 | w=27
  56. en:beta-adrenergic antagonist --- r_associated #0: 26 --> en:alpha-adrenergic agonist
    n1=en:beta-adrenergic antagonist | n2=en:alpha-adrenergic agonist | rel=r_associated | relid=0 | w=26
  57. sympathomimétiques alpha --- r_associated #0: 26 --> en:alpha-adrenergic agonist
    n1=sympathomimétiques alpha | n2=en:alpha-adrenergic agonist | rel=r_associated | relid=0 | w=26
  58. en:norfenefrine --- r_associated #0: 25 --> en:alpha-adrenergic agonist
    n1=en:norfenefrine | n2=en:alpha-adrenergic agonist | rel=r_associated | relid=0 | w=25
  59. en:ace inhibitor --- r_associated #0: 20 --> en:alpha-adrenergic agonist
    n1=en:ace inhibitor | n2=en:alpha-adrenergic agonist | rel=r_associated | relid=0 | w=20
  60. en:adrenalone hydrochloride --- r_associated #0: 20 --> en:alpha-adrenergic agonist
    n1=en:adrenalone hydrochloride | n2=en:alpha-adrenergic agonist | rel=r_associated | relid=0 | w=20
  61. en:adrenergic agonist --- r_associated #0: 20 --> en:alpha-adrenergic agonist
    n1=en:adrenergic agonist | n2=en:alpha-adrenergic agonist | rel=r_associated | relid=0 | w=20
  62. en:adrenergic alpha-2 adrenergic agonists --- r_associated #0: 20 --> en:alpha-adrenergic agonist
    n1=en:adrenergic alpha-2 adrenergic agonists | n2=en:alpha-adrenergic agonist | rel=r_associated | relid=0 | w=20
  63. en:adrenergic alpha-2 receptor agonists --- r_associated #0: 20 --> en:alpha-adrenergic agonist
    n1=en:adrenergic alpha-2 receptor agonists | n2=en:alpha-adrenergic agonist | rel=r_associated | relid=0 | w=20
  64. en:agent affecting cardiovascular system --- r_associated #0: 20 --> en:alpha-adrenergic agonist
    n1=en:agent affecting cardiovascular system | n2=en:alpha-adrenergic agonist | rel=r_associated | relid=0 | w=20
  65. en:alpha blockers/related --- r_associated #0: 20 --> en:alpha-adrenergic agonist
    n1=en:alpha blockers/related | n2=en:alpha-adrenergic agonist | rel=r_associated | relid=0 | w=20
  66. en:alpha-adrenergic agonist [epc] --- r_associated #0: 20 --> en:alpha-adrenergic agonist
    n1=en:alpha-adrenergic agonist [epc] | n2=en:alpha-adrenergic agonist | rel=r_associated | relid=0 | w=20
  67. en:angiotensin ii receptor antagonist --- r_associated #0: 20 --> en:alpha-adrenergic agonist
    n1=en:angiotensin ii receptor antagonist | n2=en:alpha-adrenergic agonist | rel=r_associated | relid=0 | w=20
  68. en:antianginals --- r_associated #0: 20 --> en:alpha-adrenergic agonist
    n1=en:antianginals | n2=en:alpha-adrenergic agonist | rel=r_associated | relid=0 | w=20
  69. en:antiarrhythmic agent --- r_associated #0: 20 --> en:alpha-adrenergic agonist
    n1=en:antiarrhythmic agent | n2=en:alpha-adrenergic agonist | rel=r_associated | relid=0 | w=20
  70. en:antiatherogenic agent --- r_associated #0: 20 --> en:alpha-adrenergic agonist
    n1=en:antiatherogenic agent | n2=en:alpha-adrenergic agonist | rel=r_associated | relid=0 | w=20
  71. en:antihypertensives, other --- r_associated #0: 20 --> en:alpha-adrenergic agonist
    n1=en:antihypertensives, other | n2=en:alpha-adrenergic agonist | rel=r_associated | relid=0 | w=20
  72. en:antiplatelet agent --- r_associated #0: 20 --> en:alpha-adrenergic agonist
    n1=en:antiplatelet agent | n2=en:alpha-adrenergic agonist | rel=r_associated | relid=0 | w=20
  73. en:araminol --- r_associated #0: 20 --> en:alpha-adrenergic agonist
    n1=en:araminol | n2=en:alpha-adrenergic agonist | rel=r_associated | relid=0 | w=20
  74. en:arrhythmic agent --- r_associated #0: 20 --> en:alpha-adrenergic agonist
    n1=en:arrhythmic agent | n2=en:alpha-adrenergic agonist | rel=r_associated | relid=0 | w=20
  75. en:aspects of adverse effects --- r_associated #0: 20 --> en:alpha-adrenergic agonist
    n1=en:aspects of adverse effects | n2=en:alpha-adrenergic agonist | rel=r_associated | relid=0 | w=20
  76. en:aspirin/simvastatin/atenolol/ramipril/thiazide capsule --- r_associated #0: 20 --> en:alpha-adrenergic agonist
    n1=en:aspirin/simvastatin/atenolol/ramipril/thiazide capsule | n2=en:alpha-adrenergic agonist | rel=r_associated | relid=0 | w=20
  77. en:besipirdine hydrochloride --- r_associated #0: 20 --> en:alpha-adrenergic agonist
    n1=en:besipirdine hydrochloride | n2=en:alpha-adrenergic agonist | rel=r_associated | relid=0 | w=20
  78. en:calcium channel agonists --- r_associated #0: 20 --> en:alpha-adrenergic agonist
    n1=en:calcium channel agonists | n2=en:alpha-adrenergic agonist | rel=r_associated | relid=0 | w=20
  79. en:cardiac adrenergic blocking agent --- r_associated #0: 20 --> en:alpha-adrenergic agonist
    n1=en:cardiac adrenergic blocking agent | n2=en:alpha-adrenergic agonist | rel=r_associated | relid=0 | w=20
  80. en:cardioplegic solutions --- r_associated #0: 20 --> en:alpha-adrenergic agonist
    n1=en:cardioplegic solutions | n2=en:alpha-adrenergic agonist | rel=r_associated | relid=0 | w=20
  81. en:cardiovascular agents, other --- r_associated #0: 20 --> en:alpha-adrenergic agonist
    n1=en:cardiovascular agents, other | n2=en:alpha-adrenergic agonist | rel=r_associated | relid=0 | w=20
  82. en:chemical aspects --- r_associated #0: 20 --> en:alpha-adrenergic agonist
    n1=en:chemical aspects | n2=en:alpha-adrenergic agonist | rel=r_associated | relid=0 | w=20
  83. en:cinnamedrine --- r_associated #0: 20 --> en:alpha-adrenergic agonist
    n1=en:cinnamedrine | n2=en:alpha-adrenergic agonist | rel=r_associated | relid=0 | w=20
  84. en:cinnamedrine hydrochloride --- r_associated #0: 20 --> en:alpha-adrenergic agonist
    n1=en:cinnamedrine hydrochloride | n2=en:alpha-adrenergic agonist | rel=r_associated | relid=0 | w=20
  85. en:clonidine --- r_associated #0: 20 --> en:alpha-adrenergic agonist
    n1=en:clonidine | n2=en:alpha-adrenergic agonist | rel=r_associated | relid=0 | w=20
  86. en:clorprenaline --- r_associated #0: 20 --> en:alpha-adrenergic agonist
    n1=en:clorprenaline | n2=en:alpha-adrenergic agonist | rel=r_associated | relid=0 | w=20
  87. en:contraindications aspect --- r_associated #0: 20 --> en:alpha-adrenergic agonist
    n1=en:contraindications aspect | n2=en:alpha-adrenergic agonist | rel=r_associated | relid=0 | w=20
  88. en:digitalis glycosides --- r_associated #0: 20 --> en:alpha-adrenergic agonist
    n1=en:digitalis glycosides | n2=en:alpha-adrenergic agonist | rel=r_associated | relid=0 | w=20
  89. en:dipivefrin --- r_associated #0: 20 --> en:alpha-adrenergic agonist
    n1=en:dipivefrin | n2=en:alpha-adrenergic agonist | rel=r_associated | relid=0 | w=20
  90. en:diuretic --- r_associated #0: 20 --> en:alpha-adrenergic agonist
    n1=en:diuretic | n2=en:alpha-adrenergic agonist | rel=r_associated | relid=0 | w=20
  91. en:dl-methylephedrine --- r_associated #0: 20 --> en:alpha-adrenergic agonist
    n1=en:dl-methylephedrine | n2=en:alpha-adrenergic agonist | rel=r_associated | relid=0 | w=20
  92. en:dl-methylephedrine hydrochloride --- r_associated #0: 20 --> en:alpha-adrenergic agonist
    n1=en:dl-methylephedrine hydrochloride | n2=en:alpha-adrenergic agonist | rel=r_associated | relid=0 | w=20
  93. en:dyslipidemics, fibric acid derivatives --- r_associated #0: 20 --> en:alpha-adrenergic agonist
    n1=en:dyslipidemics, fibric acid derivatives | n2=en:alpha-adrenergic agonist | rel=r_associated | relid=0 | w=20
  94. en:dyslipidemics, other --- r_associated #0: 20 --> en:alpha-adrenergic agonist
    n1=en:dyslipidemics, other | n2=en:alpha-adrenergic agonist | rel=r_associated | relid=0 | w=20
  95. en:ephedrine --- r_associated #0: 20 --> en:alpha-adrenergic agonist
    n1=en:ephedrine | n2=en:alpha-adrenergic agonist | rel=r_associated | relid=0 | w=20
  96. en:ephedrine sulfate --- r_associated #0: 20 --> en:alpha-adrenergic agonist
    n1=en:ephedrine sulfate | n2=en:alpha-adrenergic agonist | rel=r_associated | relid=0 | w=20
  97. en:epinephrine bitartrate --- r_associated #0: 20 --> en:alpha-adrenergic agonist
    n1=en:epinephrine bitartrate | n2=en:alpha-adrenergic agonist | rel=r_associated | relid=0 | w=20
  98. en:epinephrine hydrochloride --- r_associated #0: 20 --> en:alpha-adrenergic agonist
    n1=en:epinephrine hydrochloride | n2=en:alpha-adrenergic agonist | rel=r_associated | relid=0 | w=20
  99. en:ethylnorepinephrine --- r_associated #0: 20 --> en:alpha-adrenergic agonist
    n1=en:ethylnorepinephrine | n2=en:alpha-adrenergic agonist | rel=r_associated | relid=0 | w=20
  100. en:historical aspects qualifier --- r_associated #0: 20 --> en:alpha-adrenergic agonist
    n1=en:historical aspects qualifier | n2=en:alpha-adrenergic agonist | rel=r_associated | relid=0 | w=20
  101. en:ibopamine --- r_associated #0: 20 --> en:alpha-adrenergic agonist
    n1=en:ibopamine | n2=en:alpha-adrenergic agonist | rel=r_associated | relid=0 | w=20
  102. en:in blood --- r_associated #0: 20 --> en:alpha-adrenergic agonist
    n1=en:in blood | n2=en:alpha-adrenergic agonist | rel=r_associated | relid=0 | w=20
  103. en:in urine --- r_associated #0: 20 --> en:alpha-adrenergic agonist
    n1=en:in urine | n2=en:alpha-adrenergic agonist | rel=r_associated | relid=0 | w=20
  104. en:l-norepinephrine --- r_associated #0: 20 --> en:alpha-adrenergic agonist
    n1=en:l-norepinephrine | n2=en:alpha-adrenergic agonist | rel=r_associated | relid=0 | w=20
  105. en:mephentermine --- r_associated #0: 20 --> en:alpha-adrenergic agonist
    n1=en:mephentermine | n2=en:alpha-adrenergic agonist | rel=r_associated | relid=0 | w=20
  106. en:metaterol --- r_associated #0: 20 --> en:alpha-adrenergic agonist
    n1=en:metaterol | n2=en:alpha-adrenergic agonist | rel=r_associated | relid=0 | w=20
  107. en:methyldopa --- r_associated #0: 20 --> en:alpha-adrenergic agonist
    n1=en:methyldopa | n2=en:alpha-adrenergic agonist | rel=r_associated | relid=0 | w=20
  108. en:methyldopate --- r_associated #0: 20 --> en:alpha-adrenergic agonist
    n1=en:methyldopate | n2=en:alpha-adrenergic agonist | rel=r_associated | relid=0 | w=20
  109. en:neurotransmitter uptake inhibitors --- r_associated #0: 20 --> en:alpha-adrenergic agonist
    n1=en:neurotransmitter uptake inhibitors | n2=en:alpha-adrenergic agonist | rel=r_associated | relid=0 | w=20
  110. en:nitric oxide donors --- r_associated #0: 20 --> en:alpha-adrenergic agonist
    n1=en:nitric oxide donors | n2=en:alpha-adrenergic agonist | rel=r_associated | relid=0 | w=20
  111. en:octopamine --- r_associated #0: 20 --> en:alpha-adrenergic agonist
    n1=en:octopamine | n2=en:alpha-adrenergic agonist | rel=r_associated | relid=0 | w=20
  112. en:phenylephrine --- r_associated #0: 20 --> en:alpha-adrenergic agonist
    n1=en:phenylephrine | n2=en:alpha-adrenergic agonist | rel=r_associated | relid=0 | w=20
  113. en:phenylpropanolamine --- r_associated #0: 20 --> en:alpha-adrenergic agonist
    n1=en:phenylpropanolamine | n2=en:alpha-adrenergic agonist | rel=r_associated | relid=0 | w=20
  114. en:potassium channel blockers --- r_associated #0: 20 --> en:alpha-adrenergic agonist
    n1=en:potassium channel blockers | n2=en:alpha-adrenergic agonist | rel=r_associated | relid=0 | w=20
  115. en:potassium-sparing diuretic --- r_associated #0: 20 --> en:alpha-adrenergic agonist
    n1=en:potassium-sparing diuretic | n2=en:alpha-adrenergic agonist | rel=r_associated | relid=0 | w=20
  116. en:racephedrine --- r_associated #0: 20 --> en:alpha-adrenergic agonist
    n1=en:racephedrine | n2=en:alpha-adrenergic agonist | rel=r_associated | relid=0 | w=20
  117. en:sclerosing agent --- r_associated #0: 20 --> en:alpha-adrenergic agonist
    n1=en:sclerosing agent | n2=en:alpha-adrenergic agonist | rel=r_associated | relid=0 | w=20
  118. en:sclerosing solutions --- r_associated #0: 20 --> en:alpha-adrenergic agonist
    n1=en:sclerosing solutions | n2=en:alpha-adrenergic agonist | rel=r_associated | relid=0 | w=20
  119. en:taxonomic --- r_associated #0: 20 --> en:alpha-adrenergic agonist
    n1=en:taxonomic | n2=en:alpha-adrenergic agonist | rel=r_associated | relid=0 | w=20
  120. en:tinofedrine --- r_associated #0: 20 --> en:alpha-adrenergic agonist
    n1=en:tinofedrine | n2=en:alpha-adrenergic agonist | rel=r_associated | relid=0 | w=20
  121. en:toxicity aspects --- r_associated #0: 20 --> en:alpha-adrenergic agonist
    n1=en:toxicity aspects | n2=en:alpha-adrenergic agonist | rel=r_associated | relid=0 | w=20
  122. en:vasoactive agent --- r_associated #0: 20 --> en:alpha-adrenergic agonist
    n1=en:vasoactive agent | n2=en:alpha-adrenergic agonist | rel=r_associated | relid=0 | w=20
  123. en:vasodilators, direct-acting arterial --- r_associated #0: 20 --> en:alpha-adrenergic agonist
    n1=en:vasodilators, direct-acting arterial | n2=en:alpha-adrenergic agonist | rel=r_associated | relid=0 | w=20
  124. en:vasopressor --- r_associated #0: 20 --> en:alpha-adrenergic agonist
    n1=en:vasopressor | n2=en:alpha-adrenergic agonist | rel=r_associated | relid=0 | w=20
  125. en:vasoprotectant --- r_associated #0: 20 --> en:alpha-adrenergic agonist
    n1=en:vasoprotectant | n2=en:alpha-adrenergic agonist | rel=r_associated | relid=0 | w=20
  126. éphédrine --- r_associated #0: 20 --> en:alpha-adrenergic agonist
    n1=éphédrine | n2=en:alpha-adrenergic agonist | rel=r_associated | relid=0 | w=20
  127. agonistes du récepteur alpha-1 adrénergique --- r_associated #0: 10 --> en:alpha-adrenergic agonist
    n1=agonistes du récepteur alpha-1 adrénergique | n2=en:alpha-adrenergic agonist | rel=r_associated | relid=0 | w=10
  128. agonistes du récepteur alpha-2 adrénergique --- r_associated #0: 10 --> en:alpha-adrenergic agonist
    n1=agonistes du récepteur alpha-2 adrénergique | n2=en:alpha-adrenergic agonist | rel=r_associated | relid=0 | w=10
  129. antagoniste du récepteur de l'angiotensine II --- r_associated #0: 10 --> en:alpha-adrenergic agonist
    n1=antagoniste du récepteur de l'angiotensine II | n2=en:alpha-adrenergic agonist | rel=r_associated | relid=0 | w=10
  130. clonidine --- r_associated #0: 10 --> en:alpha-adrenergic agonist
    n1=clonidine | n2=en:alpha-adrenergic agonist | rel=r_associated | relid=0 | w=10
  131. guanfacine --- r_associated #0: 10 --> en:alpha-adrenergic agonist
    n1=guanfacine | n2=en:alpha-adrenergic agonist | rel=r_associated | relid=0 | w=10
  132. méthyldopa --- r_associated #0: 10 --> en:alpha-adrenergic agonist
    n1=méthyldopa | n2=en:alpha-adrenergic agonist | rel=r_associated | relid=0 | w=10
  133. octopamine --- r_associated #0: 10 --> en:alpha-adrenergic agonist
    n1=octopamine | n2=en:alpha-adrenergic agonist | rel=r_associated | relid=0 | w=10
  134. phénylpropanolamine --- r_associated #0: 10 --> en:alpha-adrenergic agonist
    n1=phénylpropanolamine | n2=en:alpha-adrenergic agonist | rel=r_associated | relid=0 | w=10
  135. phényléphrine --- r_associated #0: 10 --> en:alpha-adrenergic agonist
    n1=phényléphrine | n2=en:alpha-adrenergic agonist | rel=r_associated | relid=0 | w=10
  136. taxinomique --- r_associated #0: 10 --> en:alpha-adrenergic agonist
    n1=taxinomique | n2=en:alpha-adrenergic agonist | rel=r_associated | relid=0 | w=10
  137. agent bloquant adrénergique cardiaque --- r_associated #0: 5 --> en:alpha-adrenergic agonist
    n1=agent bloquant adrénergique cardiaque | n2=en:alpha-adrenergic agonist | rel=r_associated | relid=0 | w=5
  138. diurétique d'épargne potassique --- r_associated #0: 5 --> en:alpha-adrenergic agonist
    n1=diurétique d'épargne potassique | n2=en:alpha-adrenergic agonist | rel=r_associated | relid=0 | w=5
  139. en:amidephrine --- r_associated #0: 3 --> en:alpha-adrenergic agonist
    n1=en:amidephrine | n2=en:alpha-adrenergic agonist | rel=r_associated | relid=0 | w=3
Le service Rézo permet d'énumérer les relations existant pour un terme. Ce service est interrogeable par programme.
Projet JeuxDeMots - url: http://www.jeuxdemots.org
contact: mathieu.lafourcade@lirmm.fr